查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1190726

电泳设备和耗材市场 - COVID-19 的增长、趋势、影响和预测 (2023-2028)

Electrophoresis Equipment and Supplies Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 100 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，电泳设备和耗材市场预计将以 4.9% 的复合年增长率增长。

COVID-19 大流行对电泳设备和耗材市场产生了重大的积极影响。 这主要是由于电泳在COVID-19诊断中的应用。 已经开发出新的 SARS-CoV-2 检测方法，以提高 COVID-19 的检测能力。 该方法是使用传统的非实时热循环仪、CDC RT-qPCR 协议中包含的一组引物目标和琼脂糖凝胶电泳的两步端点 RT-PCR 协议。 这种新技术已导致 COVID-19 在美国和欧洲等发达国家的广泛诊断。 这对大流行期间的市场扩张做出了重大贡献。

电泳主要用于分离和分析大分子，例如蛋白质、核酸、质粒、DNA、RNA，以及这些大分子的片段。 电泳包括几种相关的分析技术，例如亲和电泳、毛细管电泳、凝胶电泳、免疫电泳、电印迹、脉衝场凝胶电泳和等电聚焦。

全球对医疗保健创新的需求正在增长。 COVID-19 迫使製药和生物技术行业开发创新药物和疫苗来对抗这种新病毒。 为此，製药领域的技术革新不断推进，而电泳在这些技术革新中扮演着重要的角色。 例如，2021 年 7 月发布的 PubMed 数据表明电泳在药物开发中的应用越来越多。 研究人员使用电泳技术分析药物。 因此，由于电泳在新药开发中的应用越来越广泛，预计研究市场在预测期内将出现强劲增长。

然而，电泳法的分析时间长是抑制市场增长的因素之一。

电泳设备和耗材的市场趋势

期待製药和生物技术公司的快速增长

毛细管凝胶电泳技术用于製药和生物技术行业，以分离质荷比随大小变化不大的大分子，例如 DNA、RNA 和蛋白质。 2021 年，在英国，医学研究慈善协会 (AMRC) 将为非工业研发支出贡献 15 亿英镑（18.2 亿美元），卫生与公共服务部 (DHSC) 将贡献约 1 英镑50 亿美元（60 亿美元）。8000 万美元）。 增加对生命科学研究的投资，以及英国政府到 2027 年将研发支出提高到 GDP 的 2.4% 和长期 GDP 的 3% 的雄心也在推动市场的增长。

电泳设备和耗材市场由製药和生物技术公司主导。 随着电泳在质量控制中越来越多地被采用，例如药物製剂中药物含量的分析、DNA 片段的鑑定和研究以及抗生素和疫苗的测试，预计在预测期内会出现类似的趋势。 例如，在 2022 年 8 月，Kymos 表示，各种类型和格式的电泳分析现在作为测试方法包含在其用于治疗性蛋白质批量测试的分析证书中。 细胞因子、血液因子、激素、单克隆抗体 (mAb)、融合蛋白等是一些可以通过电泳分析的蛋白质。 随着电泳重要性的增加，采用率也在增加，从而促进了该领域的发展。

医疗和保健领域的持续技术进步、对创新疗法和药物的需求不断增加以及涉及基因、蛋白质和生物分子的研究项目不断增加是製药和生物技术公司细分市场的主要驱动力。是一个因素。

北美将占据市场的主要份额，预计在预测期内也会如此

北美是电泳设备和耗材市场的主要参与者，原因是涉及蛋白质、基因和相关生物分子的研发项目需求增加，该地区与製药质量控制相关的严格监管问题，以及工艺验证流程。预计占据市场份额。

美国不断增加的投资和研发支出正在促进电泳设备市场的增长。 例如，根据美国国立卫生研究院数据2022，美国的研发投资从2016年的457亿美元增加到2021年的886亿美元。 因此，随着美国各地研发成本的上升，预计未来几年电泳设备和耗材市场将出现强劲增长。

要自信地鑑定和量化细胞和组织中表达的蛋白质、翻译后修饰和蛋白质复合物，需要具有高分离效率和灵敏度的强大分析方法。 近年来，由于美国和其他发达国家的这种需求，人们对毛细管电泳-质谱 (CE-MS) 的兴趣显着增长。 随着需求的增加，预计市场将在预测期内经历强劲增长。

电泳设备及耗材市场竞争分析

电泳设备和耗材市场是分散的，由几家主要参与者组成。 从市场份额的角度来看，一些主要参与者目前主导着市场。 目前主导市场的公司有 Bio-Rad Laboratories, Inc、GE Healthcare、Thermo Fisher Scientific Inc、Agilent Technologies, Inc、Merck Millipore (Merck &Co., Inc.)、PerkinElmer, Inc、QIAGEN N.V.、Lonza Group Ltd、Shimadzu株式会社、Sebia集团等

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 对创新疗法和药物的需求不断增长
    • 启动基因、蛋白质和特定生物分子的研究活动
  • 市场製约因素
    • 耗时的技术
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分

  • 按产品类型
    • 凝胶电泳系统
    • 毛细管电泳系统
    • 电泳附件
  • 通过申请
    • 学术和研究机构
    • 医院和诊断中心
    • 製药和生物技术公司
    • 其他用途
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Bio-Rad Laboratories, Inc.
    • GE Healthcare
    • Thermo Fisher Scientific Inc.
    • Agilent Technologies, Inc.
    • Merck Millipore（Merck & Co., Inc.）
    • PerkinElmer, Inc.
    • QIAGEN N.V.
    • Lonza Group Ltd
    • Shimadzu Corporation
    • Sebia Group

第7章 市场机会今后动向

简介目录
Product Code: 67988

The electrophoresis equipment and supplies market is expected to register a CAGR of 4.9% during the forecast period.

The COVID-19 pandemic had a significant positive impact on the electrophoresis equipment and supplies market. This is majorly due to the application of electrophoresis in diagnosing COVID-19. To increase COVID-19 testing capacities, a new method for SARS-CoV-2 detection was developed. The method includes using a two steps end point RT-PCR protocol, where conventional nonreal-time thermal cycler, the set of primers targets included on the CDC RT-qPCR protocol, and agarose gel electrophoresis are used. With the help of this new method, the diagnosis of COVID-19 was widely made across developed countries, such as United States and European countries. This factor contributed significantly to market growth during the pandemic.

The electrophoresis technique is mainly used to separate and analyze large molecules, such as proteins, nucleic acids, plasmids, DNA, RNA, and fragments of these macromolecules. Electrophoresis comprises several related analytical techniques, such as affinity electrophoresis, capillary electrophoresis, gel electrophoresis, immune electrophoresis, electroblotting, pulsed-field gel electrophoresis, and isoelectric focusing.

The demand for healthcare innovations has been increasing worldwide. COVID-19 forced the pharmaceutical and biotechnology industries to develop innovative drugs or vaccines that can cope with the novel virus. This led to increasing innovations in the field of pharmaceuticals, and electrophoresis plays a crucial role in these innovations. For instance, the PubMed data published in July 2021 suggests that the application of electrophoresis is on the rise in pharmaceutical development. Researchers use the electrophoresis technique for pharmaceutical analysis. Hence, with the rising use of electrophoresis in new drug development, the market studied is expected to witness strong growth over the forecast period.

However, the long analysis time associated with this technique is one of the factors hindering the market growth.

Electrophoresis Equipment & Supplies Market Trends

Pharmaceutical and Biotechnology Companies Segment is Expected to Witness Rapid Growth

Capillary gel electrophoresis techniques are used in pharmaceutical and biotechnology industries to separate large molecules or macromolecules, such as DNA, RNA, and proteins, whose mass-to-charge ratios do not vary much with size. In 2021, the Association of Medical Research Charities (AMRC) contributed GBP 1.5 billion (USD 1.82 billion) of non-industry spending on research and development in United Kingdom, while the Department of Health and Social Care (DHSC) spent around GBP 5 billion (USD 6.08 billion). Increasing investments in life sciences research and the United Kingdom government's ambition to increase R&D spending to 2.4% of GDP by 2027 and 3% over the longer term also support market growth.

The pharmaceutical and biotechnology companies segment holds a significant market share in the electrophoresis equipment and supplies market. It is anticipated to show a similar trend over the forecast period due to the growing adoption of electrophoresis in quality control of pharmaceutical formulations by analyzing the drug content of pharmaceutical formulations and identification and study of DNA fragments, and testing of antibiotics and vaccines. For instance, in August 2022, Kymos stated that electrophoretic assays in different types and formats are currently included as a testing method in the certificates of analysis for batch testing of therapeutic proteins. Cytokines, blood factors, hormones, monoclonal antibodies (mAbs), and fusion proteins are some of the proteins that can be analyzed with electrophoresis. The adoption of electrophoresis increases with its rising importance, which contributes to the growth of the segment.

Constant technological advancements in the medical and healthcare sector, the growing demand for innovative therapies and drugs, and increasing research projects on genes, proteins, and biomolecules are the key factors driving the pharmaceutical and biotechnology companies segment.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the electrophoresis equipment and supplies market due to growing demand from research and development projects involving proteins, genes, and associated biomolecules, stringent regulatory issues on pharmaceutical product quality control, and process validation processes in this region.

Increasing investments and R&D spending in United States contributes to the growth of the electrophoresis equipment market. For instance, according to the National Institute of Health data 2022, R&D investments in United States increased to USD 88.6 billion in 2021 from USD 45.7 billion in 2016. Hence, with the rise in R&D expenditure across United States, the market for electrophoresis equipment and supplies is expected to witness strong growth in the coming years.

Strong analytical methods with high separation efficiency and sensitivity are needed to confidently identify and quantify proteins, posttranslational modifications, and protein complexes expressed in cells and tissues. In recent years, interest in capillary electrophoresis-mass spectrometry (CE-MS) greatly expanded due to this demand in developed countries like United States. With the increasing demand, the market studied is believed to witness strong growth over the forecast period.

Electrophoresis Equipment & Supplies Market Competitive Analysis

The electrophoresis equipment and supplies market is fragmented and consists of several major players. In terms of market share, a few major players currently dominate the market. Some companies that currently dominate the market are Bio-Rad Laboratories, Inc, GE Healthcare, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Merck Millipore (Merck & Co., Inc.), PerkinElmer, Inc., QIAGEN N.V., Lonza Group Ltd, Shimadzu Corporation, and Sebia Group.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Demand for Innovative Therapies and Drugs
    • 4.2.2 Increasing Research Activities on Genes, Proteins, and Certain Biomolecules
  • 4.3 Market Restraints
    • 4.3.1 Time-consuming Technique
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Gel Electrophoresis Systems
    • 5.1.2 Capillary Electrophoresis Systems
    • 5.1.3 Electrophoresis Accessories
  • 5.2 By Application
    • 5.2.1 Academic and Research Institutes
    • 5.2.2 Hospitals and Diagnostics Centres
    • 5.2.3 Pharmaceutical and Biotechnology Companies
    • 5.2.4 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Bio-Rad Laboratories, Inc.
    • 6.1.2 GE Healthcare
    • 6.1.3 Thermo Fisher Scientific Inc.
    • 6.1.4 Agilent Technologies, Inc.
    • 6.1.5 Merck Millipore (Merck & Co., Inc.)
    • 6.1.6 PerkinElmer, Inc.
    • 6.1.7 QIAGEN N.V.
    • 6.1.8 Lonza Group Ltd
    • 6.1.9 Shimadzu Corporation
    • 6.1.10 Sebia Group

7 MARKET OPPORTUNITIES AND FUTURE TRENDS